|
|
| BRONZE PARTNER |
| |
Osworld, a brand name that is a regular in laboratories and unique in identity, was initiated in 1972 and has since then progressively evolved as a company, entity and brand. Today, Osworld is a well known leader in the market for Autoclave, B.O.D/Cooling Incubator, Bacteriological Incubator, Stability Chamber, Oven, Walk-in Stability Chamber and Freezers. Our equipments are being used in government and private pharmaceutical and life science research centers, hospitals and clinics, medical and pharmacy universities, food industries and chemical industries in India and many countries across the globe. The company is certified and compliant with national and international standards like ISO 9001:2008, CE and ERTL. With growing branches in India, we assure to serve you better than the best and faster than the rest.
For more info: www.osworldindia.com or
Email your query on info@osworldindia.com |
| |
| EXHIBIT PARTNERS |
| |
BUCHI India Pvt. Ltd. is the Sales Affiliates of “BUCHI Labortechnik AG, Switzerland”.
Buchi Labortechnik manufacturers of Laboratory instruments for Research in Chemistry and Quality control in food and feed industry.
The main product lines are Evaporation , Separation, Kjeldahl Distillation , Extraction and NIR solution.
They have a turnover of approx. 100 million Swiss franc worldwide and have their own sales Affiliates in countries viz: USA, Japan, China, UK, Germany, France, Italy, Thailand and India.
BUCHI India Pvt. Ltd. got incorporated on 26th October, 2007 and started providing services to Indian customer from 1st January, 2008
BUCHI India Pvt. Ltd. is responsible for Marketing & Sales of all instruments manufactured by BUCHI Labortechnik AG, Switzerland and provide after Sales Services for all Products and Applications support to the end users.
www.buchi.com |
| |
With more than 50 years' experience in the medical device arena, Owen Mumford is a specialist in the design, development & manufacture of automatic systems for self-injection. These include single dose & multi dose reusable & disposable autoinjectors & pen systems, which are suitable for a wide range of primary containers, including pre-filled glass & plastic syringes and pre-filled cartridges. Designed to meet the individual needs of our partners & those of varying user groups, these systems facilitate ease of use and improve safety and patient compliance.
With the Owen Mumford commitment, we offer a total OEM service:
- Research & Development
- Market knowledge
- Full support with focus groups & user evaluations
- IP licensing (from a large patent portfolio)
- Product Design & Testing
- Prototype manufacture & testing
- Production tooling
- Injection moulding
- Component Printing
- Clean-room manufacture
- Device Assembly (including assembly with the syringe/cartridge)
- Packaging
- Regulatory Support
- Product Lifecycle Management & After Sales Support
www.omdrugdelivery.com |
|
The Qualicaps Group is a global supplier of high-quality two-piece capsules and related equipment and technology. As a result, we offer unprecedented value in differentiable products and achieving speed to market. We have developed Quali-V®, the first pharmaceutical-grade hypromellose capsule (HPMC) with good dissolution and physicochemical properties. The Qualicaps Group has manufacturing and sales bases in Japan, North America and Europe thus has a reliable global network. The network strongly assists your global business through our complementary services.
www.qualicaps.com |
| |
ACCUTEST RESEARCH LABORATORIES (INDIA) PVT. LTD.
Total Partner in Drug Development
- Formulation Development
Development of Generic and Branded Formulations.
Solid/Liquid Orals, Topical and Injectable.
Expertise in Sustained and Controlled Release Technology.
Stability Studies as per ICH Guidelines including Zone IV studies.
Process Validation and Technology Transfer.
- BA/BE
1000+ BA/BE Studies (65% Pivotal Regulatory Studies).
Approvals from USFDA, MPA Sweden, AFFSAPS France, WHO, UK-MHRA, MCC-SA, ANVISA, BASG, MOH-UAE, DCGI, CAP and NABL.
Clinic with 369 beds and Bioanalytical facility with 34 LCMS/MS ( 239 validated methods)
Ability to do 18-20 studies per month.
- Clinical Trials
Experienced team in place handling various Phase II-IV Projects.
Access to 200+ Investigators in various therapeutic areas.
Thorough experience in Oncology, Pain Management, Dermatology and Psychiatry.
www.accutestindia.com |
| |
| |
|
|
